ProQuad Approval History
- FDA approved: Yes (First approved September 6th, 2005)
- Brand name: ProQuad
- Generic name: measles, mumps, rubella and varicella virus vaccine, live
- Dosage form: Injection
- Company: Merck & Co., Inc.
- Treatment for: Mumps Prophylaxis, Measles Prophylaxis, Rubella Prophylaxis, Varicella-Zoster, Prophylaxis
ProQuad (measles, mumps, rubella and varicella virus vaccine, live) is a vaccine indicated for active immunization for the prevention of measles, mumps, rubella, and varicella in children 12 months through 12 years of age.
Development History and FDA Approval Process for ProQuad
|Sep 6, 2005||Proquad Merck & Co., Inc. - Treatment for Measles, Mumps, Rubella and Varicella Vaccination|
|Nov 4, 2004||Merck Files Biologics License Application for Proquad With U.S. Food and Drug Administration|
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.